ASX
Botanix Pharmaceuticals Ltd
BOT:ASX•Healthcare
Sensitive ASX Announcement
Investigators Meeting Completed for BTX 1503 Phase 2 Trial
Published: 23/07/18, 09:34am (AEST)•3 pages